期刊文献+

OPN、VEGF、MVD的表达与垂体腺瘤侵袭性的关系 被引量:3

Expressions of osteopontin, VEGF and MVD and the association with tumor invasiveness of pituitary adenoma
下载PDF
导出
摘要 目的探讨肿瘤侵袭相关基因骨桥蛋白(OPN)、血管内皮生长因子(VEGF)的表达和微血管密度(MVD)与垂体腺瘤侵袭性的关系。方法将80例垂体腺瘤手术标本分为侵袭组42例和非侵袭组38例,采用免疫组化方法检测OPN、VEGF蛋白的表达。检测CD34标记的血管内皮细胞并计数MVD;并采用统计学方法分析这些指标与垂体腺瘤侵袭性的关系。结果侵袭组的OPN、VEGF表达均较非侵袭组增高(均P〈0.05),其MVD值也较非侵袭组增高(P〈0.01),但这些指标在不同年龄、性别、肿瘤组织学类型患者间的差异无统计学意义(均P〉0.05),OPN与VEGF的表达呈正相关(r=0.492.P〈0.01)。结论OPN影响垂体腺瘤生物学行为改变可能与促使肿瘤血管形成有关。OPN、VEGF和MVD可作为判断垂体腺瘤侵袭性和评估预后的良好生物学指标,三者联合检测有望更客观评价垂体腺瘤的侵袭性。 Objective To examine the expressions of osteopontin (OPN), vascular endothelial growth factor (VEGF) and micro-vessel density (MVD) in pituitary adenomas, and the correlation with tumor invasiveness. Methods Total 80 surgical specimens of pituitary adenoma, including 42 invasive case and 38 non-invasive case were collected. The expressions of OPN,VEGF and MVD were detected by immunohistochemistry, their correlation with clinicopathological characteristics of the tumor were analyzed. Results The expressions of OPN,VEGF and MVD were significantly higher in invasive group than those in non-invasive group (P〈 0.05 or P〈 0.01 ) ; but they were not correlated with age, sex and histological types of patients. The expression of OPN was positively correlated with VEGF (r = 0.492,P〈 0.01 ). Conclusion The upregulated OPN and VEGF may be associated with angiogenesis and invasiveness of pituitary adenoma.
出处 《浙江医学》 CAS 2011年第11期1580-1582,1585,共4页 Zhejiang Medical Journal
基金 浙江省医药卫生科技计划项目(20078172) 杭州市医药卫生科学研究重点项目(2006Z002)
关键词 垂体腺瘤 骨桥蛋白 血管内皮生长因子 微血管密度 Pituitary adenoma Osteopontin Vascular endothelial growth factor Micro-vessel density
  • 相关文献

参考文献10

二级参考文献23

共引文献23

同被引文献37

  • 1杨伟,曲元明,徐广明,韩韬,牟成志.在垂体腺瘤中TSP-1和TGF-β1的表达及其与微血管密度的关系[J].中华内分泌代谢杂志,2007,23(1):44-46. 被引量:6
  • 2Jasek E, Furgal-Borzych A, Lis GJ, et al. Microvessel density and area in pituitary microadenomas [J]. Endocr Pathol, 2009, 20(4): 221-226.
  • 3Zhang Y, He N, Zhou J, et al. The relationship between MRI invasive features and expression of EMMPRIN, galectin-3, and microvessel density in pituitary adenoma [J]. Clin Imaging, 2011, 35(3): 165-173.
  • 4Cristina C, Perez-Millan MI, Luque G, et ol. VEGF and CD31 association in pituitary adenomas [J]. Endocr Pathol, 2010, 21(3): 154-160.
  • 5Miyajima K, Takekoshi S, Itoh J, etal. Inhibitory effects of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344 Rats: animal model of VEGF-targeted therapy for human endocrine tumors [J]. Acta Histochem Cytochem, 2010, 43 (2): 33-44.
  • 6Korsisaari N, Ross J, Wu X, et al. Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1 [J]. Clin Cancer Res, 2008, 14(1): 249-258.
  • 7Chamaon K, Kanakis D, Mawrin C, et al. Transcripts of PTTG and growth factors bFGF and IGF-1 are correlated in pituitary adenomas [J]. Exp Clin Endocrinol Diabetes, 2010, 118(2): 121-126.
  • 8Say A, Rotondo F, Syro L V, et al. Biomarkers of pituitary neoplasms [J]. Anticancer Res, 2012, 32(11): 4639-4654.
  • 9Zhang X, Horwitz GA, Heaney AP, et al. Pituitary tumor transforming gene (PTTG) expression in pituitary adeno- mas [J]. J Clin Endocrinol Metab, 1999, 84(2): 761-767.
  • 10Salehi F, Kovacs K, Scheithauer BW, et al. Immunohisto- chemical expression of pituitary tumor transforming gene (PTTG) in pituitary adenomas: a correlative study of tumor subtypes [J]. Int J Surg Pathol, 2010, 18(1): 5-13.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部